Joachim Burman Selected Research

Joachim Burman Research Topics

22	Multiple Sclerosis 04/2022 - 06/2012
8	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2015
7	Relapsing-Remitting Multiple Sclerosis 01/2022 - 10/2013
5	Infections 01/2022 - 11/2018
5	Inflammation (Inflammations) 06/2021 - 06/2012
4	Disease Progression 02/2021 - 01/2018
3	Chronic Progressive Multiple Sclerosis 01/2019 - 03/2016
2	COVID-19 01/2022 - 01/2021
2	Nausea 02/2021 - 11/2018
2	Vertigo (Positional Vertigo) 02/2021 - 11/2018
2	Huntington Disease (Huntington's Disease) 01/2021 - 11/2019
2	Cytopenia 01/2021 - 01/2020
1	Bacterial Meningitis 02/2021
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Epilepsy (Aura) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Neoplasms (Cancer) 01/2020
1	Atrophy 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 12/2017
1	Crohn Disease (Crohn's Disease) 12/2017
1	Torticollis (Wryneck) 09/2015
1	Neuromyelitis Optica (Devic's Disease) 02/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2012
1	Encephalomyelitis (Myeloencephalitis) 05/2012

6	Rituximab (Mabthera)FDA Link 01/2022 - 11/2018
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2016
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2018
3	Alemtuzumab (Campath)FDA Link 01/2021 - 01/2021
3	Natalizumab (Tysabri)FDA Link 01/2020 - 01/2017
2	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 01/2020
2	Dimethyl FumarateIBA 01/2022 - 10/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020 - 01/2020
1	Biological ProductsIBA 04/2022
1	Monoclonal AntibodiesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	VaccinesIBA 01/2022
1	InterferonsIBA 01/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021
1	proenkephalinIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 10/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Interferon-betaIBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2019
1	Tyrosine (L-Tyrosine)FDA Link 11/2019
1	pyrimidineIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	nitazoxanide (NTZ)FDA Link 01/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2015
1	abobotulinumtoxinA FDA Link 09/2015
1	Type A Botulinum Toxins (Botox)FDA Link 09/2015
1	Aquaporin 4IBA 02/2015
1	AntibodiesIBA 02/2015
1	CytokinesIBA 12/2014
1	Interleukin-12 (IL 12)IBA 05/2012

10	Therapeutics 01/2022 - 05/2012
10	Hematopoietic Stem Cell Transplantation 01/2021 - 06/2012
9	Stem Cell Transplantation 01/2022 - 10/2013
3	Transplantation 01/2020 - 02/2015
2	Aftercare (After-Treatment) 01/2021 - 09/2015
1	Treatment Delay 01/2022
1	Off-Label Use 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Injections 01/2020
1	Intramuscular Injections 09/2015